Ask about money problems with a short validated questionnaire when treatment starts, and route those at risk to financial navigators before bills cause missed doses.
Financial toxicity is associated with non-adherence, bankruptcy and worse survival, and is invisible unless asked about. The COST-FACIT instrument is validated and short. The proposal is universal screening at diagnosis and at each treatment change, with automatic referral to financial navigation (benefits, assistance programmes, employment rights, billing review), and inclusion of the score as a routinely collected outcome in registries and trials.
Shares Money after treatment: what the cost of cancer does once the treatment has finished, Patients lack understanding, navigation and agency, Prices and value.
Shares Money after treatment: what the cost of cancer does once the treatment has finished, Prices and value.
Shares Money after treatment: what the cost of cancer does once the treatment has finished, Patients lack understanding, navigation and agency.
Shares Money after treatment: what the cost of cancer does once the treatment has finished, Prices and value.
Shares Patients lack understanding, navigation and agency, Prices and value.
Shares Money after treatment: what the cost of cancer does once the treatment has finished, Prices and value.
Shares Patients lack understanding, navigation and agency, Prices and value.
Shares Money after treatment: what the cost of cancer does once the treatment has finished, Prices and value.